IP Library Assignment 060703/0034
Patent Assignment
Reel/Frame 060703/0034

Assignment of Assignor's Interest

Recorded: 2022-08-03 Pages: 3
Assignor
WUXI BIOLOGICS (CAYMAN) INC.
Executed: 2020-03-19
Assignee
WUXI BIOLOGICS IRELAND LIMITED
ONE SPENCER DOCK, NORTH WALL QUAY, DUBLIN, IRELAND
Covered Properties (2)
Novel Anti-CD3EPSILON Antibodies
Application: 17/816,731 →
Publication: US 2023/0203159
Novel Anti-CD3EPSILON Antibodies
Application: 17/816,732 →
Publication: US 2023/0192850
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 3, 2022
From: LI, JING; MEI, QIN
To: WUXI BIOLOGICS (SHANGHAI) CO., LTD.
Reel/Frame 060703/0004 →
Assignment of Assignor's Interest Aug 3, 2022
From: WUXI BIOLOGICS (SHANGHAI) CO., LTD.
To: WUXI BIOLOGICS (CAYMAN) INC.
Reel/Frame 060703/0016 →